Wilmington, DE -- (SBWIRE) -- 10/17/2013 -- Equity Profile Report expands its NYSE Decliners Weekly Watch List adding Merck & Co. Inc. (NYSE:MRK) and Juniper Networks, Inc. (NYSE:JNPR).
Merck & Co. Inc. (NYSE:MRK) a company that provides various health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products worldwide is currently down (-0.03%) on 10,128,278 shares traded after Merck has announced that it is presenting pharmacokinetic data this week about investigational formulations of a once-daily dose of Isentress at the European AIDS Conference. Merck & Co. Inc. (NYSE:MRK) is currently down (-6.52%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NYSE Decliners Watch List.
Click Here to find out what other Investors are saying about Merck & Co. Inc. (NYSE:MRK)
Juniper Networks, Inc. (NYSE:JNPR) a company that designs, develops, and sells products and services that provide network infrastructure for networking requirements of service providers, enterprises, governments, and research and public sector organizations worldwide is currently down (-1.93%) on 3,571,357 shares traded after Juniper Networks upgraded by MKM Partners. Juniper Networks, Inc. (NYSE:JNPR) is currently down (-10.62%) from its recent 52-week high which has prompted Equity Profile Report to add the stock to their NYSE Decliners Watch List.
Click Here to find out what other Investors are saying about Juniper Networks, Inc. (NYSE:JNPR)
Equityprofilereport.com monitors and scans the markets for stock related signals as well as any external factors that might bring trading opportunities.
Through a vast network of IR professionals Equityprofilereport.com is often aware of several large investor awareness campaigns being deployed.
Timing is important when trading Small Caps and Penny Stocks.
Simply sign up for free and start receiving exclusive alerts.
Subscribe Here: http://www.Equityprofilereport.com
Equityprofilereport.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please visit Equityprofilereport.com website, for complete risks and disclosures.
Equity Profile Report
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)